Xanthomicrol shifts the ERα/ERβ balance and promotes a less aggressive phenotype in SKOV‑3 ovarian cancer cells
Authors:
- 2 September 2026
- journal article
- Published by Taylor & Francis in Natural Product Research
- p. 1-9
Abstract
No abstract availableFunding Information
- Fondo de Investigación en Salud, Instituto Mexicano del Seguro Social (FIS/IMSS/PROT/G17-2/1720/2017-785-009)
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación (492151/282566)
- Instituto Mexicano del Seguro Social (99096716)
This publication has 29 references indexed in Scilit:
- Phytoestrogen Signal Pathways and Estrogen Signaling in Ovarian Cancer: A Narrative ReviewPhytotherapy Research, 2025
- Revealing the role of bisphenol A on prostate cancer progression and identifying potential targets: A comprehensive analysis from population cohort to molecular mechanismEcotoxicology and Environmental Safety, 2025
- Investigation of structural, electronic, and antioxidant properties of calycopetrin and xanthomicrol as two polymethoxylated flavones using DFT calculationsStructural Chemistry, 2022
- C-myc promotes miR-92a-2-5p transcription in rat ovarian granulosa cells after cadmium exposureToxicology and Applied Pharmacology, 2021
- Xanthohumol attenuates isoprenaline-induced cardiac hypertrophy and fibrosis through regulating PTEN/AKT/mTOR pathwayEuropean Journal of Pharmacology, 2021
- Inhibitory effect of flavonoid xanthomicrol on triple‐negative breast tumor via regulation of cancer‐associated microRNAsPhytotherapy Research, 2020
- Antiangiogenic Activity of Xanthomicrol and Calycopterin, Two Polymethoxylated Hydroxyflavones in BothIn VitroandEx VivoModelsPhytotherapy Research, 2014
- Dietary phyto-oestrogens and the risk of ovarian and endometrial cancers: findings from two Australian case–control studiesBritish Journal of Nutrition, 2013
- Estrogens and epithelial ovarian cancerGynecologic Oncology, 2004
- Absence of estrogen receptor-β expression in metastatic ovarian cancerObstetrics & Gynecology, 2000